More needs to be done globally to fight cancer

January 07, 2016

In recent years, research funded by AICR has led to important discoveries such as the identification of a 'rogue' gene which allows cancer cells to spread by Dr Andrew Chantry and his team at the University of East Anglia. This raises the possibility of developing drugs to turn off the gene WWP2 and prevent cancers from spreading.

Late last year, AICR Fellow, Professor Eric So, King's College, University of London, discovered that leukaemic stem cells can be reversed to a pre-leukaemic stage by turning off a protein called beta-catenin found in the blood.

 Said Dr Matfield: "These are exciting new discoveries and a good example of how basic research into cancer such as that funded by AICR can open up the potential to develop new methods to treat the disease.

 "One of the very first grants we awarded was in 1980, to Dr P R Salmon of University College Hospital, London, who was awarded a one-year grant to study photodynamic therapy - the use of lasers and light-sensitive drugs to treat cancer. The research we funded, along with a number of other research projects, led to the first use of photodynamic therapy on patients in 1981 and the establishment of the National Medical Laser Centre at UCH in 1986."

SOURCE Association for International Cancer Research